IP Library Granted Patent US 10,463,046
Granted Patent B2
US 10,463,046 · App. 15/718,997 · Granted Nov 5, 2019

Antimicrobial coatings capable of reducing the number of murine norovirus inoculated thereon

Inventors: Daniel Moros (New York, NY); Craig Grossman (Point Roberts, WA)
Assignee: Allied Bioscience, Inc.
A01N55/00A01N25/02A01N33/08A01N59/16A61L2/00B05D1/02B05D1/04B05D7/14B05D7/544C08G77/26C09D5/14C09D179/02C09D183/08C23C26/00C08K3/22C08K2003/2241C09D183/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,046
App. No.
15/718,997
Granted
Nov 5, 2019
Kind
B2
Abstract

The present disclosure provides antimicrobial coatings on a surface comprising a reactive silanol and triethanolamine. In various examples the reactive silane is 3-chloropropylsilane triol. The coating is capable of reducing the number of Murine norovirus and E. Coli inoculated on the dried coating. In various examples, the coating further comprises a mixture of peroxotitanium acid and peroxo-modified anatase sol. The compositions may be electrostatically sprayed on the surface, and in certain examples, a mixture of silanol and triethanolamine is spray-coated on the surface followed by an aqueous mixture of peroxotitanium acid and peroxo-modified anatase sol.

Claims (20)

1. An antimicrobial coating on a surface of a substrate, the coating comprising triethanolamine, a mixture of peroxotitanium acid and peroxo-modified anatase sol, and a silane having structure VI:

2. The antimicrobial coating of claim 1 , wherein the substrate is paper and melamine resin laminate.

3. The antimicrobial coating of claim 2 , wherein the antimicrobial coating exhibits ≥1.50 log viral count reduction in Murine norovirus 4 hours after initial inoculation of the coating with Murine norovirus.

4. The antimicrobial coating of claim 1 , wherein the substrate is stainless steel.

5. The antimicrobial coating of claim 4 , wherein the antimicrobial coating exhibits about a 2.3 log viral count reduction in Murine norovirus 4 hours after initial inoculation of the coating with Murine norovirus.

6. The antimicrobial coating of claim 4 , wherein the antimicrobial coating exhibits about a 2.58 log viral count reduction in Murine norovirus 6 hours after initial inoculation of the coating with Murine norovirus.

7. A method of coating a surface of a substrate with the antimicrobial coating of claim 1 , which method comprises:

(a) spray-coating on the surface a methanolic composition comprising triethanolamine and a silane having structure VI:

(b) allowing the methanolic composition to dry;

(c) spray-coating on the surface an aqueous composition of peroxotitanium acid and peroxo-modified anatase sol; and

(d) allowing the aqueous composition to dry, forming the antimicrobial coating.

8. The method of claim 7 , wherein the substrate is stainless steel.

9. The method of claim 8 , wherein the spray-coating of both the methanolic composition and the aqueous composition comprise electrostatic spraying.

10. The method of claim 9 , wherein the antimicrobial coating exhibits about a 5.33 log reduction in E. Coli 1 hour after initial inoculation of the coating with E. Coli.

11. The method of claim 9 , wherein the antimicrobial coating exhibits about a 6.71 log reduction in E. Coli 4 hours after initial inoculation of the coating with E. Coli.

12. The method of claim 8 , wherein neither the spray-coating of the methanolic composition nor the spray-coating of the aqueous composition comprises electrostatic spraying.

13. The method of claim 12 , wherein the antimicrobial coating exhibits about a 0.47 log reduction in E. Coli 1 hour after initial inoculation of the coating with E. Coli.

14. The method of claim 12 , wherein the antimicrobial coating exhibits about a 5.92 log reduction in E. Coli 4 hours after initial inoculation of the coating with E. Coli.

15. The method of claim 7 , wherein allowing the methanolic composition to dry comprises allowing at least 90 weight percent of the methanol to evaporate from the surface.

16. The method of claim 7 , wherein allowing the aqueous composition to dry comprises allowing at least 90 weight percent of the water to evaporate from the surface.

Assignments (2)
CHANGE OF NAME Recorded May 27, 2022
From: ALLIED BIOSCIENCE, INC.
To: SRFC BIO, INC.
Reel/Frame 060205/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2017
From: MOROS, DANIEL; GROSSMAN, CRAIG
To: ALLIED BIOSCIENCE, INC.
Reel/Frame 043729/0755 →
Continuity (5)
Division 15041974 · Feb 11, 2016
Continuation In Part 14932840 · Nov 4, 2015
Provisional Application 62114998 · Feb 11, 2015
Provisional Application 62075020 · Nov 4, 2014
Related Publication 20180014545A1 · Jan 18, 2018